GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ahn-Gook Pharmaceutical Co Ltd (XKRX:001540) » Definitions » Other Operating Expense

Ahn-Gook Pharmaceutical Co (XKRX:001540) Other Operating Expense : ₩20,017 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Ahn-Gook Pharmaceutical Co Other Operating Expense?

Ahn-Gook Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was ₩5,403 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩20,017 Mil.

Ahn-Gook Pharmaceutical Co's quarterly Other Operating Expense declined from Sep. 2024 (₩5,084 Mil) to Dec. 2024 (₩4,952 Mil) but then increased from Dec. 2024 (₩4,952 Mil) to Mar. 2025 (₩5,403 Mil).

Ahn-Gook Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2022 (₩20,992 Mil) to Dec. 2023 (₩17,487 Mil) but then increased from Dec. 2023 (₩17,487 Mil) to Dec. 2024 (₩19,114 Mil).


Ahn-Gook Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Ahn-Gook Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ahn-Gook Pharmaceutical Co Other Operating Expense Chart

Ahn-Gook Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26,062.78 24,975.32 20,991.83 17,486.83 19,114.34

Ahn-Gook Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,499.70 4,577.70 5,084.49 4,952.45 5,402.61

Ahn-Gook Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩20,017 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ahn-Gook Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ahn-Gook Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ahn-Gook Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
993-75, Daerim-Dong, Yeongdeungpo-Gu, Seoul, KOR, 150-072
Ahn-Gook Pharmaceutical Co Ltd manufactures and markets medicines. The company is famous for medicine for ophthalmology. The company also engages in various prescription medicines.

Ahn-Gook Pharmaceutical Co Headlines

No Headlines